Form 4 for BBNX Beta Bionics, Inc.
Accepted 2026-09-10 16:30:09 ET · period of report 2026-09-09 · accession 0002048497-26-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-10 16:30 | 2026-09-09 | BBNX | Hopman Mark | Chief Commercial Off | S - Sale | $18.46 | -36.9K | 87.2K | -30% | -$680.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-09 | S | D | 36,870 | $18.46 | 87,157 | D | — | — | (F1) Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026. |